Total Payments
$5,536
2024 Payments
$201.45
Companies
20
Transactions
167
Medicare Patients
1,067
Medicare Billing
$76,129
Payment Breakdown by Category
Food & Beverage$5,531 (99.9%)
Education$4.52 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,531 | 166 | 99.9% |
| Education | $4.52 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,060 | 32 | $0 (2024) |
| Novo Nordisk Inc | $829.33 | 25 | $0 (2023) |
| Gilead Sciences, Inc. | $471.21 | 15 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $385.15 | 8 | $0 (2023) |
| Amgen Inc. | $373.60 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $363.10 | 12 | $0 (2023) |
| Lilly USA, LLC | $350.69 | 16 | $0 (2023) |
| GlaxoSmithKline, LLC. | $350.21 | 6 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $336.94 | 7 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $170.83 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $201.45 | 3 | E.R. Squibb & Sons, L.L.C. ($149.08) |
| 2023 | $1,540 | 36 | AstraZeneca Pharmaceuticals LP ($338.37) |
| 2022 | $2,133 | 67 | AstraZeneca Pharmaceuticals LP ($503.57) |
| 2021 | $1,661 | 61 | Novo Nordisk Inc ($247.77) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2024 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $149.08 | General |
| Category: Hematology | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Respiratory | ||||||
| 03/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Inflammation | ||||||
| 12/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $134.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $112.25 | General |
| Category: Respiratory | ||||||
| 08/07/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.26 | General |
| 07/17/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Obesity | ||||||
| 06/28/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Gastroenterology | ||||||
| 05/23/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Diabetes | ||||||
| 05/17/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/12/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $29.61 | General |
| Category: Bone Health | ||||||
| 05/11/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $87.66 | General |
| Category: DIABETES | ||||||
| 05/11/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: DIABETES | ||||||
| 05/09/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $81.10 | General |
| Category: Diabetes | ||||||
| 05/04/2023 | Merck Sharp & Dohme LLC | VARIVAX (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: VACCINE | ||||||
| 05/03/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Gastroenterology | ||||||
| 04/27/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/25/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: Diabetes | ||||||
| 04/14/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: Cardio-renal | ||||||
| 04/05/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: KRYSTEXXA | ||||||
| 03/28/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $108.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/21/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Diabetes | ||||||
| 03/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 130 | 161 | $29,569 | $7,411 |
| 2022 | 10 | 378 | 486 | $86,704 | $29,632 |
| 2021 | 6 | 280 | 413 | $71,793 | $23,195 |
| 2020 | 8 | 279 | 348 | $56,399 | $15,892 |
Total Patients
1,067
Total Services
1,408
Medicare Billing
$76,129
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 113 | $18,419 | $3,624 | 19.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 25 | 25 | $10,000 | $3,326 | 33.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 23 | 23 | $1,150 | $461.15 | 40.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 79 | 79 | $31,600 | $10,511 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 105 | 212 | $34,556 | $9,643 | 27.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 18 | 18 | $4,500 | $2,376 | 52.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $4,800 | $2,011 | 41.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 79 | 79 | $3,950 | $1,547 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 12 | $2,700 | $949.42 | 35.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 28 | 28 | $1,764 | $870.87 | 49.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 12 | 12 | $900.00 | $822.48 | 91.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 18 | 18 | $1,134 | $564.47 | 49.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 16 | 16 | $800.00 | $336.88 | 42.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 111 | 241 | $39,283 | $11,666 | 29.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 61 | 61 | $24,250 | $8,262 | 34.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 14 | $3,150 | $1,355 | 43.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 61 | 61 | $3,050 | $1,220 | 40.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 19 | 20 | $1,260 | $363.92 | 28.9% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 15 | 16 | $800.00 | $327.53 | 40.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 53 | 53 | $21,200 | $6,351 | 30.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 89 | 154 | $25,102 | $5,211 | 20.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 11 | 11 | $2,750 | $1,303 | 47.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 54 | 54 | $2,700 | $1,044 | 38.7% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 11 | 11 | $825.00 | $670.78 | 81.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 30 | 32 | $2,016 | $657.65 | 32.6% |
About Yim Ping Mo, NP
Yim Ping Mo, NP is a Adult Health healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2016. The National Provider Identifier (NPI) number assigned to this provider is 1841653458.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Yim Ping Mo, NP has received a total of $5,536 in payments from pharmaceutical and medical device companies, with $201.45 received in 2024. These payments were reported across 167 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($5,531).
As a Medicare-enrolled provider, Mo has provided services to 1,067 Medicare beneficiaries, totaling 1,408 services with total Medicare billing of $76,129. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Health
- Other Specialties Nurse Practitioner
- Location Stanford, CA
- Active Since 03/31/2016
- Last Updated 12/31/2025
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1841653458
Products in Payments
- Rybelsus (Drug) $495.95
- Kerendia (Drug) $385.15
- FARXIGA (Drug) $352.35
- SHINGRIX (Biological) $333.23
- LOKELMA (Drug) $251.52
- EVENITY (Biological) $221.76
- STIOLTO RESPIMAT (Drug) $200.59
- Ozempic (Drug) $182.27
- MOUNJARO (Drug) $180.82
- XIFAXAN (Drug) $170.83
- JARDIANCE (Drug) $162.51
- BREZTRI (Drug) $160.95
- REBLOZYL (Biological) $149.08
- NURTEC ODT (Drug) $148.33
- TRULICITY (Drug) $138.88
- VRAYLAR (Drug) $134.70
- XARELTO (Drug) $125.09
- Prolia (Biological) $124.88
- PREVNAR 13 (Biological) $114.33
- Vemlidy (Drug) $96.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Stanford
Jong-Mi Lee, Np, NP
Adult Health — Payments: $147,391
Adult Health $147,391
Martina Speight, Np, NP
Adult Health — Payments: $132,764
Adult Health $132,764
Carol Barch, Np, NP
Adult Health — Payments: $75,946
Adult Health $75,946
Mr. Matthew Burke, Aprn, APRN
Adult Health — Payments: $42,176
Adult Health $42,176
Lindsay Martin, Np, NP
Adult Health — Payments: $36,732
Adult Health $36,732
Nancy Robles, Np, NP
Adult Health — Payments: $3,464
Adult Health $3,464